A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.
Carter HaagAndrew AlexisValeria AokiRobert BissonnetteAndrew BlauveltRaj ChovatiyaMichael J CorkSimon G DanbyLawrence EichenfieldKilian EyerichMelinda J GooderhamEmma Guttman-YasskyDirk-Jan HijnenAlan IrvineNorito KatohDedee Frances MurrellYael A LeshemAdriane LevinIda VittrupJill I OlydamRaquel L OrfaliAmy PallerYael Renert-YuvalDavid RosmarinJonathan Ian SilverbergJacob ThyssenSonja StänderNick StefanovicGail ToddJiaDe YuEric SimpsonPublished in: The British journal of dermatology (2024)
The decision to initiate a JAKinib should be shared among patient and provider, accounting for AD severity and personal risk/benefit assessment, including consideration of baseline health risk factors, monitoring requirements and treatment costs.